Bharat Book

Indian Pharmaceutical Market Outlook

Press Release   •   Feb 05, 2013 12:19 IST


“Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural market penetration and expanded access to healthcare attracting Big Pharma investment” provides in-depth analysis of the trends, issues and challenges facing the Indian pharmaceutical market. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. The Indian pharmaceutical industry grew from $0.8 billion in 1980 to $21.73 billion in 2010 and is expected to grow further as Multinational Companies (MNCs) enter the market. Although pharmaceutical giants such as GlaxoSmithKline (GSK) have been present in the market for years, the rising income of the middle-class population, changing patent laws, low-cost skilled labor and low-priced infrastructure in India have attracted other MNCs. With the current scenario, the market is expected to grow at a Compound Annual Growth Rate (CAGR) of 12% during the 2011–2015 period. Branded generics are expected to become more prevalent in India as many global players are planning to launch them after their patents expire.

The once highly fragmented Indian pharmaceutical industry is undergoing strategic consolidations with the aim of emerging as a highly organized sector. With the inflow of MNCs’ R&D operations the industry will continue to experience a trend of M&A. Deals and acquisitions are set to continue due to low-cost infrastructure and labor as patent expiries and the thin pipelines of major companies will cause revenues to fall.

The Indian government has implemented various initiatives to increase insurance coverage and reduce healthcare costs, such as the National Rural Health Mission and Jan Aushadhi. A revised pricing policy was also proposed in 2011, which will increase government control to over 60% of drugs.

Rising income levels, changing disease patterns, increasing reach of healthcare, reduced out-of-pocket expenditure and growth of new products such as generics and biosimilars are expected to drive growth in the future.


- Macroeconomic environment of the pharmaceutical industry in India, covering demographic analysis, drivers, and barriers
- Important industry characteristics, looking at healthcare policies, regulations, distribution, pricing, taxation, spending, insurance and reimbursement
- Market analysis of segments such as prescription medicines, biotechnology, over-the-counter medicines and Contract Research and Manufacturing Services (CRAMS)
- Annualized market data from 2005 to 2010 for important therapeutic segments
- Competitive profiling of five major domestic and international companies operating in the Indian pharmaceutical market
- Analysis of licensing, partnership and M&A deals that took place between 2007 and 2011

Reasons to buy

- Develop market-entry and market-expansion strategies by identifying the leading segments poised for strong growth
- Device a more tailored country strategy through understanding key drivers of and barriers to the pharmaceutical market
- Develop key strategic initiatives by understanding leading companies’ key focus areas
- Accelerate and strengthen your market position by identifying key companies for M&A and strategic partnerships

Companies Mentioned

Abbott Laboratories
Dr. Reddy’s Laboratories
Cipla Limited
Ranbaxy Laboratories Limited

Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 9
2 Indian Pharmaceutical Market Outlook – Introduction 10
3 Indian Pharmaceutical Market Outlook – Overview 11
3.1 Global Pharmaceutical Industry Landscape 11
3.2 Macro View of the Indian Pharmaceutical Sector 12
3.3 Demographic Analysis 13
3.3.1 Population Size, Growth, and Structure 13
3.3.2 Crude Death Rate 15
3.3.3 Infant Mortality Rate 16
3.3.4 Life Expectancy at Birth 17
3.4 Driver and Barriers 19
3.4.1 Drivers 19
3.4.2 Barriers 21
3.5 SWOT Analysis of Indian Pharmaceutical Industry 22

For more information kindly visit :
Indian Pharmaceutical Market Outlook


Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter:
Our Blogs:

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.